Tulathromycin Patent Expiration
About Veterinary Tulathromycin
Tulathromycin is used in drugs marketed by 10 different companies: Elanco Us Inc, Zoetis Inc, Parnell Technologies Pty Ltd, Intervet Inc, Ceva Sante Animale, Hikma Pharmaceuticals Usa Inc, Norbrook Laboratories Ltd, Cronus Pharma Specialities India Private Ltd, Virbac Ah Inc, Bimeda Animal Health Ltd.
Other drugs containing Tulathromycin are: Tulissin 25 , Macrosyn , Tulieve , Tulathromycin injection
Veterinary Tulathromycin Patents
Given below is the list of patents protecting Tulathromycin, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| Draxxin | US6583274 | 02 May, 2020 | ZOETIS INC. |
| Draxxin | US6329345 | 18 Nov, 2019 | ZOETIS INC. |
| Draxxin | US6420536 | 24 May, 2019 | ZOETIS INC. |
| Draxxin | US6936592 | 29 May, 2018 | ZOETIS INC. |
| Draxxin | US6777393 | 29 May, 2018 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6583274 | 02 May, 2020 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6329345 | 18 Nov, 2019 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6420536 | 24 May, 2019 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6936592 | 29 May, 2018 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6777393 | 29 May, 2018 | ZOETIS INC. |
Tulathromycin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List